Metropolitan Life Insurance Company (MetLife)’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-277
Closed -$37.4K 2378
2022
Q1
$37.4K Sell
277
-753
-73% -$79.4K ﹤0.01% 1753
2021
Q4
$134K Buy
1,030
+309
+43% +$39.1K ﹤0.01% 2289
2021
Q3
$67.6K Sell
721
-454
-39% -$46.2K ﹤0.01% 2712
2021
Q2
$120K Buy
+1,175
New +$205K ﹤0.01% 2502
2021
Q1
Sell
-441
Closed -$151K 2589
2020
Q4
$151K Buy
+441
New +$104K ﹤0.01% 2129

Other funds holding LONA

Metropolitan Life Insurance Company (MetLife)'s LONA Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 277 shares — an estimated $37.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LONA in Q4 2020 and held it in 5 quarters. The position peaked at $151K in Q4 2020. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 277 LeonaBio Inc shares in Q2 2022, an estimated $37.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in LeonaBio Inc in Q4 2020 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s LeonaBio Inc position peaked at $151K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.